Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Heart Test Laboratories Q4 EPS $(1.86) Beats $(2.25) Estimate, Sales $4.350M

Author: Benzinga Newsdesk | July 24, 2025 03:32pm
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(1.86) per share which beat the analyst consensus estimate of $(2.25) by 17.33 percent. The company reported $4.350 million in sales this quarter.

Posted In: HSCS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist